Hepatitis B trials in China

In China 103 Also abroad 191

103 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
SA1211 Injection Phase 1 Study
Where
Changchun
Age
18 years to 65 years
People
80
Run by
Suzhou Siran Biotechnology Co.,Ltd.
See details and how to joinNCT07275918
No phaseTaking people
Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance
Where
Fuzhou
Age
18 years and over
People
40
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07257562
No phaseTaking people
Risk Factors Affecting MSC Efficacy in ACLF Patients
Where
Guangzhou
Age
18 years and over
People
446
Run by
Sun Yat-sen University
See details and how to joinNCT07198854
Phase 2Taking people
A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
Where
Guangzhou
Age
18 years and over
People
369
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT06425341
Phase 4Not yet taking people in China
Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B
Where
Guangzhou
Age
3 years to 18 years
People
113
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT07231276
No phaseTaking people
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
Where
Shanghai
Age
18 years and over
People
33,000
Run by
Huashan Hospital
See details and how to joinNCT04896255
No phaseTaking people
Immune Dynamics in the Natural History of Chronic HBV Infection
Where
Guangzhou
Age
1 year to 80 years
People
5,000
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT07137247
No phaseTaking people
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
Where
Anyang, Guangzhou, Hebi, Jiaozuo, Jiayuguan, Jinan, Jiyuan, Kaifeng, Linyi, Luohe, Luoyang, Nanyang, Ningbo, Pingdingshan, Pingdu, Pujiang, Rizhao, Sanmenxia, Shangqiu, Xinxiang, Xinyang, Xuchang, Yantai, Zhengzhou, Zhongshan, Zhoukou, Zhumadian, Zibo
Age
18 years and over
People
15,000
Run by
The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07169656
Phase 4Taking people
Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
Where
Hangzhou
Age
20 years to 40 years
People
50
Run by
First People's Hospital of Hangzhou
See details and how to joinNCT05853718
Phase 3Not yet taking people in China
A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB
Where
Changchun
Age
18 years to 65 years
People
1,300
Run by
Shanghai Zhimeng Biopharma, Inc.
See details and how to joinNCT07095855
No phaseNot yet taking people in China
A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
Where
Beijing, Changsha, Changzhi, Foshan, Fuzhou, Guangzhou, Guiyang, Jincheng, Jinzhong, Lanzhou, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Shiyan, Taiyuan, Zhuhai
Age
18 years to 75 years
People
735
Run by
Beijing Friendship Hospital
See details and how to joinNCT07087041
No phaseTaking people
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
Where
Xi'an
Age
18 years to 70 years
People
1,500
Run by
First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT07079150
Phase 1Taking people
HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
Where
Shanghai
Age
18 years to 65 years
People
19
Run by
Changhai Hospital
See details and how to joinNCT06885710
No phaseNot yet taking people in China
Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
Where
Anfu, Ankang, Anning, Anqing, Anshan, Anyue, Baise City, Baoding, Baotou, Beihai, Beijing, Bengbu, Benxi, Bihua, Binzhou, Bozhou, Cangzhou, Changchun, Changji, Changle, Changxing, Changzhi, Changzhou, Chaoyang, Chengdu, Chifeng, Chizhou, Chuzhou, Dali, Dalian, Dandong, Daqing, Datong, Donggang, Dongguan, Dongtai, Dongying, Enshi, Ezhou, Fengcheng, Fenyang, Foshan, Fuxin, Fuyang, Fuzhou, Ganzhou, Gaomi, Guangzhou, Guilin, Haikou, Hailin, Hami, Handan, Hangzhou, Hanzhong, Harbin, Hebei, Hefei, Hegang, Heihe, Heilongjiang, Hengshui, Hetian, Heze, Hezhou, Hohhot, Huai'an, Huainan, Huangshan City, Huangshi, Hubei, Huozhou, Jiamusi, Ji’an, Jiangmen, Jianping, Jiaozhou, Jiexiu, Jilin City, Jimo, Jinan, Jincheng, Jingzhou, Jinhua, Jining, Jinxian, Jinzhong, Jinzhou, Jiujiang, Jixi, Junxian, Karamay, Kunming, Laixi, Laizhou, Lanzhou, Lianyungang, Linfen, Linkou, Linxia, Linyi, Lishui, Liuzhou, Longnan, Longyan, Lu'an, Lüliang, Ma’anshan, Macheng, Maoming, Meishan, Mudanjiang, Nanchang, Nanchong, Nangong, Nanjing, Nanning, Nanping, Nantong, Neimeng, Ningbo, Ningcheng, Ordos, Panjin, Pingdu, Pingliang, Pingxiang, Pingyang, Putian, Qingdao, Qingyuan, Qingzhou, Qinhuangdao, Qinzhou, Qiqihar, Quanzhou, Rizhao, Rui’an, Sanming, Shandong, Shangcheng, Shanghai, Shangli, Shangrao, Shawan, Shenyang, Shenzhen, Shijiazhuang, Shiyan, Shouguang, Sichuan, Songyuan, Suqian, Suzhou, Tai’an, Taihe, Taiyuan, Taizhou, Tangshan, Tengzhou, Tianjin, Tongjiang, Tongliao, Tongling, Ürümqi, Weifang, Weihai, Wenzhou, Wu’an, Wuhai, Wuhan, Wuwei, Wuxi, Wuzhou, Xiamen, Xi'an, Xi’an, Xiaogan, Xingtai, Xining, Xinjiang, Xintai, Xiushui, Xizang, Xuancheng, Xuzhou, Yanan, Yanbian, Yancheng, Yangquan, Yangzhou, Yantai, Yibin, Yichang, Yichun, Yinchuan, Yingkou, Yingtan, Yining, Yizheng, Yulin, Yuncheng, Zaozhuang, Zhangjiakou, Zhanjiang, Zhenjiang, Zhongshan, Zibo, Zigong, Zouping
Age
30 years and over
People
1,500
Run by
Peking University First Hospital
See details and how to joinNCT07007286
Phase 3Taking people
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Where
Beijing, Bengbu, Changsha, Chongqing, Guizhou, Hangzhou, Henan, Luzhou, Nanchang, Nanjing, Ningbo, Shanghai, Shenzhen, Xinxiang, Yanbian, Zhenjiang, Zunyi
Age
18 years to 65 years
People
248
Run by
Beijing Continent Pharmaceutical Co, Ltd.
See details and how to joinNCT05905172
Phase 3Taking people
Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers
Where
Guangzhou
Age
18 years to 75 years
People
136
Run by
Sun Yat-sen University
See details and how to joinNCT06966232
No phaseTaking people
Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
Where
Beijing, Changsha, Guangzhou, Shenzhen, Shijiazhuang, Wenzhou
Age
20 years to 40 years
People
210
Run by
Guangzhou 8th People's Hospital
See details and how to joinNCT06947356
Phase 4Taking people
Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients
Where
Guangzhou
Age
18 years to 60 years
People
5,000
Run by
Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT05182463
No phaseNot yet taking people in China
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
Where
Ankang, Anyang, Beihai, Beijing, Binzhou, Changzhi, Changzhou, Chengdu, Dalian, Dongguan, Dongying, Foshan, Guangzhou, Haikou, Handan, Hefei, Hepu, Heze, Jiangmen, Lanzhou, Lhasa, Liaocheng, Linfen, Liuzhou, Longyan, Luoyang, Luzhou, Nanchang, Nanning, Nanyang, Putian, Qingdao, Quanzhou, Queshan, Shangcheng, Shanghai, Shangqiu, Shaoguan, Shenzhen, Shihezi, Shijiazhuang, Suzhou, Tai’an, Taiyuan, Ürümqi, Weifang, Weishi, Wuhan, Xiamen, Xi'an, Xi’an, Xichang, Xining, Xinxiang, Xixian, Xuchang, Yantai, Yongcheng, Yulin, Yuncheng, Zhenzhou, Zhongshan, Zhumadian, Zibo
Age
1 year to 13 years
People
2,000
Run by
Beijing 302 Hospital
See details and how to joinNCT06926647
No phaseNot yet taking people in China
Effects of Peginterferon Consolidation Therapy on Hepatic cccDNA Dynamics in CHB Patients Achieving Clinical Cure.
Where
Xiamen
Age
18 years to 65 years
People
30
Run by
Xiamen Hospital of Traditional Chinese Medicine
See details and how to joinNCT06920329
Phase 4Not yet taking people in China
Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg
Where
Shanghai
Age
18 years to 65 years
People
360
Run by
Huashan Hospital
See details and how to joinNCT06900166
Phase 3Not yet taking people in China
Optimal Timing of Hepatitis B Vaccination After Transplants
Where
Tianjin
Age
16 years and over
People
1,500
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06888479
No phaseTaking people
Non-Invasive Model for Fibrosis Regression in HBV Patients
Where
Beijing
Age
18 years and over
People
1,100
Run by
Beijing Friendship Hospital
See details and how to joinNCT06874127
Phase 2Taking people
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Where
Beijing
Age
35 years to 65 years
People
45
Run by
Fujian Akeylink Biotechnology Co., Ltd.
See details and how to joinNCT06263959
No phaseTaking people
Research on Clinical Recovery and Maintenance Strategies for CHB
Where
Beijing
Age
18 years to 65 years
People
285
Run by
Beijing Municipal Administration of Hospitals
See details and how to joinNCT06803368